Cu(II) enhances the effect of Alzheimer's amyloid-β peptide on microglial activation

被引:28
|
作者
Yu, Fengxiang [1 ]
Gong, Ping [1 ]
Hu, Zhuqin [2 ]
Qiu, Yu [1 ]
Cui, Yongyao [1 ]
Gao, Xiaoling [1 ]
Chen, Hongzhuan [1 ]
Li, Juan [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China
基金
对外科技合作项目(国际科技项目); 中国国家自然科学基金;
关键词
Cu(II)-A beta complex; Aggregation; Microglia; Reactive oxygen species; Tumor necrosis factor-alpha; Nitric oxide; NF-kappa B; NITRIC-OXIDE SYNTHASE; INFLAMMATORY RESPONSE; HYDROGEN-PEROXIDE; N-ACETYLCYSTEINE; MOUSE MODEL; DISEASE; EXPRESSION; LIPOPOLYSACCHARIDE; PROLIFERATION; NEUROTOXICITY;
D O I
10.1186/s12974-015-0343-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Aggregated forms of amyloid-beta (A beta) peptides are important triggers for microglial activation, which is an important pathological component in the brains of Alzheimer's patients. Cu(II) ions are reported to be coordinated to monomeric A beta, drive A beta aggregation, and potentiate A beta neurotoxicity. Here we investigated whether Cu(II) binding modulates the effect of A beta on microglial activation and the subsequent neurotoxicity. Methods: A beta peptides were incubated with Cu(II) at an equimolar ratio to obtain the Cu(II)-A beta complex. Primary and BV-2 microglial cells were treated with Cu(II)-A beta, A beta, or Cu(II). The tumor necrosis factor-alpha (TNF-alpha) and nitric oxide levels in the media were determined. Extracellular hydrogen peroxide was quantified by a fluorometric assay with Amplex Red. Mitochondrial superoxide was detected by MitoSOX oxidation. Results: Incubation of Cu(II) with A beta confers different chemical properties on the resulting complex. At the subneurotoxic concentrations, Cu(II)-A beta (but not A beta or Cu(II) alone) treatment induced an activating morphological phenotype of microglia and induced the microglial release of TNF-alpha and nitric oxide as well as microglia-mediated neuronal damage. Cu(II)-A beta-triggered microglial activation was blocked by nuclear factor (NF)-kappa B inhibitors and was accompanied with NF-kappa B activation. Moreover, Cu(II)-A beta induced hydrogen peroxide release, which was not affected by NADPH oxidase inhibitors. Mitochondrial superoxide production was increased after Cu(II)-A beta stimulation. N-acetyl-cysteine, a scavenger of reactive oxygen species (ROS), inhibited Cu(II)-A beta-elicited microglial release of TNF-alpha and nitric oxide as well as the microglia-mediated neurotoxic effect. Conclusion: Our observations suggest that Cu(II) enhances the effect of A beta on microglial activation and the subsequent neurotoxicity. The Cu(II)-A beta-triggered microglial activation involves NF-kappa B activation and mitochondrial ROS production.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Alzheimer's Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence
    Gosztyla, Maya L.
    Brothers, Holly M.
    Robinson, Stephen R.
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (04) : 1495 - 1506
  • [22] Amyloid-β deposition effects microglial activation in Parkinson's disease
    Ghadery, Christine
    Koshimori, Yuko
    Kim, Jinhee
    Coakeley, Sarah
    Harris, Madeleine
    Christopher, Leigh
    Rusjan, Pablo
    Lang, Anthony
    Houle, Sylvain
    Strafella, Antonio
    MOVEMENT DISORDERS, 2017, 32 : S50 - S50
  • [23] Amyloid-β peptide metabolism and Alzheimer's disease.
    Iwata, N
    Saido, TC
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 14P - 14P
  • [24] Restored degradation of the Alzheimer's amyloid-β peptide by targeting amyloid formation
    Crouch, Peter J.
    Tew, Deborah J.
    Du, Tai
    Nguyen, Diem Ngoc
    Caragounis, Aphrodite
    Filiz, Gulay
    Blake, Rachel E.
    Trounce, Ian A.
    Soon, Cynthia P. W.
    Laughton, Katrina
    Perez, Keyla A.
    Li, Qiao-Xin
    Cherny, Robert A.
    Masters, Colin L.
    Barnham, Kevin J.
    White, Anthony R.
    JOURNAL OF NEUROCHEMISTRY, 2009, 108 (05) : 1198 - 1207
  • [25] An "Amyloid-β Cleaner" for the Treatment of Alzheimer's Disease by Normalizing Microglial Dysfunction
    Liu, Ruiyuan
    Yang, Jun
    Liu, Linying
    Lu, Zhiguo
    Shi, Zhuyan
    Ji, Weihong
    Shen, Jie
    Zhang, Xin
    ADVANCED SCIENCE, 2020, 7 (02)
  • [26] REGULATION OF MICROGLIAL AMYLOID-β PHAGOCYTOSIS IN THE THERAPEUTIC STRATEGY FOR ALZHEIMER'S DISEASE
    Takata, Kazuyuki
    Kitamura, Yoshihisa
    Morikawa, Shigehiro
    Inubushi, Toshiro
    Tooyama, Ikuo
    Taniguchi, Takashi
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 194 - 194
  • [27] Process and mechanism of microglial phagocytosis of amyloid-β peptide
    Tsuchiya, Daju
    Kitamura, Yoshihisa
    Shimohama, Shun
    Taniguchi, Takashi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2005, 125 : 108 - 110
  • [28] Affinity of Cu+ for the Copper-Binding Domain of the Amyloid-β Peptide of Alzheimer's Disease
    Feaga, Heather A.
    Maduka, Richard C.
    Foster, Monique N.
    Szalai, Veronika A.
    INORGANIC CHEMISTRY, 2011, 50 (05) : 1614 - 1618
  • [29] Alterations in microglial activation and amyloid deposits in Alzheimer's disease
    Ouchi, Yasuomi
    Yokokura, Masamichi
    Yagi, Shunsuke
    Kikuchi, Mitsuru
    Yoshikawa, Etsuji
    Futatsubashi, Masami
    Oboshi, Yumi
    Sakamoto, Masanobu
    Ueki, Takatoshi
    NEUROSCIENCE RESEARCH, 2010, 68 : E304 - E304
  • [30] Inhibition of catalase activity with 3-amino-triazole enhances the cytotoxicity of the Alzheimer's amyloid-β peptide
    Milton, NGN
    NEUROTOXICOLOGY, 2001, 22 (06) : 767 - 774